Singapore’s decision to reimpose some restrictions despite the country’s rapid vaccine rollout raises questions about its long-term strategy of living with COVID-19. The government’s caution will hold back the recovery in the near term, and its recent stumbles suggest other places still pursuing a zero-COVID policy will be in little hurry to follow Singapore’s lead.
Become a client to read more
This is premium content that requires an active Capital Economics subscription to view.
Already have an account?
You may already have access to this premium content as part of a paid subscription.
Sign in to read the content in full or get details of how you can access it
Register for free
Sign up for a free account to gain:
- Unlock additional content
- Register for Capital Economics events
- Receive email updates and economist-curated newsletters
- Request a free trial of our services